Lynparza 150 mg/1

Lynparza 150 mg tablets are a pharmaceutical product used in specific medical treatments. This medication is designed to target certain genetic mutations for therapeutic benefits.

Lynparza 150 mg tablets are primarily used in the treatment of advanced ovarian cancer and other conditions linked to specific genetic mutations. This medication is often prescribed for patients who have undergone prior treatments. Lynparza is a PARP inhibitor, which works by blocking an enzyme involved in repairing damaged DNA in cancer cells.

Common effects of Lynparza 150 mg tablets may include fatigue, nausea, and anemia. Some users might experience vomiting, diarrhea, or changes in appetite. It's important to consult a healthcare provider if these effects persist or worsen.

Lynparza 150 mg tablets should be handled with care and stored as directed. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their doctor about any pre-existing conditions or allergies before starting this medication.

Lynparza 150 mg tablets may interact with certain medications, including those metabolized by the liver. It is advisable to avoid alcohol while taking this medication. Always consult a healthcare provider before combining Lynparza with other treatments.